PHS
RVMD icon

PFM Health Sciences’s Revolution Medicines RVMD Stock Holding History

PFM Health Sciences’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.7M Sell
140,770
-10,683
-7% -$1.08M 1.25% 24
2025
Q4 		$12.1M Sell
151,453
-179,616
-54% -$11.8M 1.2% 31
2025
Q3 		$15.5M Buy
+331,069
New +$13M 1.19% 29
2021
Q1 		– Sell
-209,116
Closed -$8.28M – 106
2020
Q4 		$8.28M Sell
209,116
-151,197
-42% -$5.98M 0.29% 73
2020
Q3 		$12.5M Buy
+360,313
New +$9.98M 0.58% 57

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PFM Health Sciences's RVMD Position: Q1 2026 in Review

PFM Health Sciences reduced its Revolution Medicines (RVMD) stake by 7.1% in Q1 2026, selling an estimated $1.08M and leaving 140,770 shares worth $13.7M. The position accounts for 1.25% of the portfolio, ranked #24.

PFM Health Sciences first reported a position in RVMD in Q3 2020 and has held it in 5 quarters since. The position peaked at $15.5M in Q3 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • PFM Health Sciences held 140,770 shares of Revolution Medicines worth $13.7M as of Q1 2026.
  • PFM Health Sciences sold 10,683 Revolution Medicines shares in Q1 2026, an estimated $1.08M.
  • Revolution Medicines made up 1.25% of PFM Health Sciences's portfolio in Q1 2026, its #24 holding.
  • PFM Health Sciences first reported a position in Revolution Medicines in Q3 2020 and has held it in 5 quarters since.
  • PFM Health Sciences's Revolution Medicines position peaked at $15.5M in Q3 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.